Furthermore, dynamic changes of PD-L1 expression in tumor cells might occur before or during therapy with PD-1/PD-L1 inhibitors, leading to different sensitivity to PD-1/PD-L1 blockade which would similarly be missed by a single biopsy. Here, CD274 is linked to neoplasm.